health canada semaglutide approves 1st generic version of Ozempic in the country Health Canada approves first GLP-1

These patients may benefit from a slower titration (holding at an intermediate dose for 8 weeks instead of 4) or a reduced maintenance dose of 1.7 mg, which is permitted under the FDA label [4]

adults said theyve taken a GLP-1 drug, used to treat type 2 diabetes and obesity, according to a Kaiser Family Foundation poll published in May 2024

However, ongoing safety monitoring on Hers depends on patient-initiated check-ins rather than mandatory follow-up labs or clinical assessments, which may delay detection of dose-related complications or emerging health concerns

How GLP-1 receptor agonists work in the body Before evaluating safety during lactation, you need to understand what these molecules actually do

A., Warren, F